Hyperthermic Perfusion as Treatment Modality for Oncological Procedures: Present and Future Perspectives (EP Video)
Peter Van den Barselaar discusses the use of hyperthermic perfusion for various oncological procedures (18:11 minutes).
World's Largest Resource for Cardiovascular Perfusion
Peter Van den Barselaar discusses the use of hyperthermic perfusion for various oncological procedures (18:11 minutes).
We investigated factors associated with transfusion requirements in totally endoscopic coronary artery bypass on the arrested heart (AH-TECAB).
We showed that plasma CysC and urinary NGAL could reliably predict the development of acute kidney injury. Measurement of early biochemical markers in plasma and urine, individually and combination, may predict the development of cardiac surgery-associated acute kidney injury in children.